SMTL ID : 2ank.1

orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.46 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x N12: N-[(1R)-2-[(1-{[({6-[AMINO(IMINO)METHYL]PYRIDIN-3-YL}METHYL)AMINO]CARBONYL}CYCLOPENTYL)AMINO]-1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]GLYCINE(Non-covalent)

N12.1: 17 residues within 4Å: Chain A: H.43, Y.47, W.50, E.94, N.95, L.96, D.199, A.200, S.205, V.225, S.226, W.227, G.228, E.229, G.230, C.231, G.238 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.47, A:W.50, A:L.96, A:W.227, A:W.227 Hydrogen bonds: A:A.200, A:S.226, A:G.228, A:G.230, A:G.230 Water bridges: A:D.232, A:R.233, A:F.239, A:Y.240

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lange, U.E.W. et al., Orally active thrombin inhibitors. Part 2: optimization of the P2-moiety. BIOORG.MED.CHEM.LETT. (2006)

Release Date

2006-11-14

Peptides

Thrombin heavy chain: A
Thrombin light chain: B
synthetic peptide: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
P

Thrombin heavy chain

Thrombin light chain

synthetic peptide

Related Entries With Identical Sequence